Author details

Full Name

Andrew E Sloan

Affiliation

ORCID

Career Start Year

1994

Papers

213

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36781873	Multiple plasma membrane reporters discern LHFPL5 region that blocks trafficking to the plasma membrane.		2023
35999374	Novel 3D magnetic resonance fingerprinting radiomics in adult brain tumors: a feasibility study.	Eur Radiol	2023
36394838	Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial.	JAMA Oncol	2023
36581779	ABTC-0904: targeting glioma stem cells in GBM: a phase 0/II study of hedgehog pathway inhibitor GDC-0449.	J Neurooncol	2023
36695968	Comparison of Near-Infrared Imaging Agents Targeting the PTPmu Tumor Biomarker.		2023
34700192	Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma.	Translational Oncology	2022
36017117	Multidisciplinary approaches to gliosarcoma: A case report and review of the literature.	Clinical Case Reports (discontinued)	2022
35879332	Integrin Î±3Î²1 promotes vessel formation of glioblastoma-associated endothelial cells through calcium-mediated macropinocytosis and lysosomal exocytosis.	Nature Communications	2022
35867099	Commentary: A Novel 5-Aminolevulinic Acid-Enabled Surgical Loupe System-A Consecutive Brain Tumor Series of 11 Cases.	Operative Neurosurgery	2022
35611270	Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent <i>IDH</i> wild-type glioblastoma.	Neurooncol Adv	2022
36321293	Stereotactic radiosurgery and resection for treatment of multiple brain metastases: a systematic review and analysis.	Neurosurgical Focus	2022
36470898	Federated learning enables big data for rare cancer boundary detection.	Nat Commun	2022
36452274	Glioma stem cells activate platelets by plasma-independent thrombin production to promote glioblastoma tumorigenesis.	Neurooncol Adv	2022
35315939	A volume-independent conformity index for stereotactic radiosurgery.	Med Phys	2022
35212383	Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.	Neuro Oncol	2022
34953280	Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2).	Mol Immunol	2022
34825292	Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments.	Journal of Neuro-Oncology	2022
34877209	Treating Recurrent Brain Metastases Using GammaTile Brachytherapy: A Case Report and Dosimetric Modeling Method.	Cureus	2021
33959715	Impact of race on care, readmissions, and survival for patients with glioblastoma: an analysis of the National Cancer Database.	Neurooncol Adv	2021
33521638	Multi-institutional noninvasive in vivo characterization of <i>IDH</i>, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk).	Neurooncol Adv	2021
33611709	Laser interstitial thermotherapy (LITT) for the treatment of tumors of the brain and spine: a brief review.	J Neurooncol	2021
33611702	Guidelines in the management of CNS tumors.	J Neurooncol	2021
34097171	Radiation Necrosis from Stereotactic Radiosurgery-How Do We Mitigate?	Curr Treat Options Oncol	2021
33977758	Limited brain metastases: a narrative review.	Ann Palliat Med	2021
32979059	Radiomic analysis of magnetic resonance fingerprinting in adult brain tumors.	Eur J Nucl Med Mol Imaging	2021
33027815	A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.	Neurosurgery	2021
34632872	Monte Carlo Dose Calculation Using MRI Based Synthetic CT Generated by Fully Convolutional Neural Network for Gamma Knife Radiosurgery.	Technol Cancer Res Treat	2021
34761331	Independently validated sex-specific nomograms for predicting survival in patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825.	J Neurooncol	2021
31076762	Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization.	Neurosurgery	2020
32027343	Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.	JAMA Oncol	2020
32315434	Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation.	Neurosurgery	2020
32191542	Cancer Imaging Phenomics via CaPTk: Multi-Institutional Prediction of Progression-Free Survival and Pattern of Recurrence in Glioblastoma.	JCO Clin Cancer Inform	2020
31621885	An independently validated survival nomogram for lower-grade glioma.	Neuro Oncol	2020
32152622	AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium.	Neuro Oncol	2020
31705229	Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study.	Clin Exp Metastasis	2020
31605846	Morbidity and Mortality After Burr Hole Craniostomy Versus Craniotomy for Chronic Subdural Hematoma Evacuation: A Single-Center Experience.	World Neurosurgery	2020
32823285	A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.	Neurosurgery	2020
32541784	Dual Role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma.	Nat Commun	2020
32642726	Treatment and surgical factors associated with longer-term glioblastoma survival: a National Cancer Database study.	Neurooncol Adv	2020
32642694	Proteins inform survival-based differences in patients with glioblastoma.	Neurooncol Adv	2020
32698368	Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies.	International Journal of Molecular Sciences	2020
33124191	SATB2 drives glioblastoma growth by recruiting CBP to promote FOXM1 expression in glioma stem cells.	EMBO Mol Med	2020
33014395	Association of metabolic syndrome with glioblastoma: a retrospective cohort study and review.	Neurooncol Pract	2020
30989622	Racial/ethnic differences in survival for patients with gliosarcoma: an analysis of the National cancer database.	J Neurooncol	2019
31748746	Longitudinal molecular trajectories of diffuse glioma in adults.	Nature	2019
31780762	Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases.	Sci Rep	2019
31675723	Association of cancer center type with treatment patterns and overall survival for patients with sacral and spinal chordomas: an analysis of the National Cancer Database from 2004 to 2015.	J Neurosurg Spine	2019
31881020	Multiscale, multimodal analysis of tumor heterogeneity in IDH1 mutant vs wild-type diffuse gliomas.	PLoS One	2019
31608326	An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.	Neurooncol Adv	2019
30649489	Advances in multidisciplinary therapy for meningiomas.	Neuro Oncol	2019